Загрузка...
Phase I/II adaptive design for drug combination oncology trials
Existing statistical methodology on dose finding for combination chemotherapies has focused on toxicity considerations alone in finding a maximum tolerated dose combination to recommend for further testing of efficacy in a phase II setting. Recently, there has been increasing interest in integrating...
Сохранить в:
| Опубликовано в: : | Stat Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4258389/ https://ncbi.nlm.nih.gov/pubmed/24470329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6097 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|